Abstract PR03: Genetic mechanisms of immune evasion in colorectal cancer
Marios Giannakis(Broad Institute), Shuji Ogino(Broad Institute), Michael J. Quist(University of California, Los Angeles), Xinmeng Jasmine Mu(Pfizer (United States)), Catherine J. Wu(Dana-Farber Cancer Institute), Charles S. Fuchs(University of Southern California), Levi A. Garraway(Broad Institute), Jonathan A. Nowak(Brigham and Women's Hospital), Thomas J. Hudson(Ontario Institute for Cancer Research), Daniel K. Wells(Parker Institute for Cancer Immunotherapy), Tsuyoshi Hamada(Brigham and Women's Hospital), William M. Grady(Seattle University), Catherine S. Grasso(University of California, Los Angeles), Charles M. Connolly(Fred Hutch Cancer Center), Sachet A. Shukla(The University of Texas MD Anderson Cancer Center), Antoni Ribas(University of California, Los Angeles), Reiko Nishihara(Harvard University), David A. Wheeler(Baylor College of Medicine), Jesse M. Zaretsky(Washington University in St. Louis), Riki Peters(Fred Hutch Cancer Center)
Cited by 4
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Pembrolizumab versus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2015|5.8k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k